{"id":"W2944589946","doi":"10.1136/ejhpharm-2019-eahpconf.403","title":"4CPS-254 Biosimilar rituximab – a year beyond","year":2019,"lang":"en","type":"article","venue":"Section 4: Clinical pharmacy services","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Kidney Foundation of Canada","keywords":"Biosimilar; Rituximab; Medicine; Discontinuation; Rheumatoid arthritis; Pharmacy; Retrospective cohort study; Internal medicine; Oncology; Lymphoma; Family medicine","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002853674,0.0002150294,0.0002851325,0.0006179478,0.0005213507,0.001514294,0.00046135,0.001306143,0.03324343],"category_scores_gemma":[0.004209328,0.0001093893,0.000549519,0.0006958432,0.0004679278,0.0008637526,0.0008316491,0.001402001,0.01086356],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001690533,"about_ca_system_score_gemma":0.001924171,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002425318,"about_ca_topic_score_gemma":0.001913402,"domain_scores_codex":[0.9982777,0.0003571129,0.0001869244,0.0001748118,0.0007589165,0.0002445343],"domain_scores_gemma":[0.9964461,0.000513843,0.000767984,0.0003276881,0.001069317,0.0008751564],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.005972326,0.001335593,0.0838408,0.001004797,0.0002766961,0.005593663,0.00040866,0.0006077723,0.01591654,0.007783786,0.3062259,0.5710335],"study_design_scores_gemma":[0.0003777009,0.002110028,0.05712342,0.0005176091,0.00008207264,0.005753341,0.0002839934,0.0004761086,0.006690073,0.00140021,0.9251521,0.00003336838],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5483142,0.06919532,0.007478002,0.06588458,0.01537906,0.001179925,0.02739718,0.001549049,0.2636226],"genre_scores_gemma":[0.8097158,0.01438456,0.005469346,0.03050036,0.006385123,0.0003665404,0.02642331,0.0003738018,0.1063811],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03324343,"threshold_uncertainty_score":0.1112104,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03496363757777717,"score_gpt":0.3810492240157845,"score_spread":0.3460855864380074,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}